about
Role of Toll-like receptors in adjuvant-augmented immune therapies.Transcription factor NF-E2-related factor 1 impairs glucose metabolism in miceTranscription factor Nrf1 negatively regulates the cystine/glutamate transporter and lipid-metabolizing enzymesNitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafishFish soluble Toll-like receptor 5 (TLR5S) is an acute-phase protein with integral flagellin-recognition activity.Tissue-restricted expression of Nrf2 and its target genes in zebrafish with gene-specific variations in the induction profiles.Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction.Loss of Nrf2 in mice evokes a congenital intrahepatic shunt that alters hepatic oxygen and protein expression gradients and toxicityDiscovery of an NRF1-specific inducer from a large-scale chemical library using a direct NRF1-protein monitoring system.Halofuginone enhances the chemo-sensitivity of cancer cells by suppressing NRF2 accumulation.A Homeostatic Shift Facilitates Endoplasmic Reticulum Proteostasis through Transcriptional Integration of Proteostatic Stress Response Pathways.Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes.Hypoxia-sensitive reporter system for high-throughput screening.Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms.Modulation of double-stranded RNA recognition by the N-terminal histidine-rich region of the human toll-like receptor 3.Lipoteichoic acid downregulates FcepsilonRI expression on human mast cells through Toll-like receptor 2.Sensing bacterial flagellin by membrane and soluble orthologs of Toll-like receptor 5 in rainbow trout (Onchorhynchus mikiss).Mild oxidative stress activates Nrf2 in astrocytes, which contributes to neuroprotective ischemic preconditioning.Prediction of the prototype of the human Toll-like receptor gene family from the pufferfish, Fugu rubripes, genome.Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis.Teleost TLR22 recognizes RNA duplex to induce IFN and protect cells from birnaviruses.Significance of the N-terminal histidine-rich region for the function of the human toll-like receptor 3 ectodomain.N-terminal binding site in the human toll-like receptor 3 ectodomain.Induction of erythropoietin gene expression in epithelial cells by chemicals identified in GATA inhibitor screenings.Time-resolved Fluorescent Detection for Glucose Using a Complex of Luminescent Layered Titanates and Enzymes.DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine-producing metabolic pathway.Nrf2 activation attenuates genetic endoplasmic reticulum stress induced by a mutation in the phosphomannomutase 2 gene in zebrafish.A ubiquitin-proteasome inhibitor bortezomib suppresses the expression of CYP11B2, a key enzyme of aldosterone synthesis.Furan- and Thiophene-2-Carbonyl Amino Acid Derivatives Activate Hypoxia-Inducible Factor via Inhibition of Factor Inhibiting Hypoxia-Inducible Factor-1.Analysis of the interaction between human TLR3 ectodomain and nucleic acidsLamprey TLRs with properties distinct from those of the variable lymphocyte receptorsFish soluble Toll-like receptor (TLR)5 amplifies human TLR5 response via physical binding to flagellin
P50
Q25257661-47DC6921-114F-4B90-AD61-0A515BD1113DQ28244260-FDF4F433-EB81-4B4E-8603-85844FC8BCB5Q28245245-26C6FBCD-3E2B-4C1B-82C6-A560F4C7DD31Q30586026-6E56CAFB-19AB-4166-A2A6-DD2494D8844DQ33211657-D8610DF7-0AF2-44D3-92D3-34402B66F10FQ34064777-895BA988-607E-4831-9B00-BD623B63D720Q34080304-C2BE7C0A-D08A-47E8-B69A-09ECE9AD7129Q34737012-1459F2FF-6E72-4CA7-823E-F4F5AF8B2776Q35622081-395B628F-3A15-425E-B914-5AD0EC728F46Q36236732-DF3E8DBA-A043-45D1-8278-445839960E84Q38289898-C7B2B5FC-3E68-4903-BC13-F201CEE9F4C2Q38870765-907142A7-8B21-4152-8F85-3F2BEF73EEBBQ38902853-9422F80C-E836-4CD7-A25A-C3F5627AC479Q39441131-CCF2451C-08B1-437E-814D-2B8CF439275CQ39973456-0B462505-74D2-4F12-B507-18824CAEDAEEQ40137003-2C9E71B3-C017-4B03-A976-1CCA1E7DB8B8Q42466865-2ED32B83-963E-4716-AA5C-1B145D0505FDQ42563477-DCD30524-145E-4673-85F0-82E04CC8D0BFQ42594447-A7F1340E-BB31-4641-A662-78DD96B4AAA0Q43242090-75013C34-EE75-462E-BF87-1A4BC110FA4BQ43553362-D6607367-DA56-4291-AF36-DC5E0FAE7579Q45345600-9485D72D-7669-4AD0-934A-F24017E7B26DQ46888457-3546437E-8D2F-4622-817B-12223B30FDEAQ47634204-AC3845B7-345B-434D-B01A-393CDE26B2ACQ47692431-478ED22C-5F5B-4257-8041-0D3AD6D98051Q48222451-4D5A0244-BC1E-4F5F-A5FD-190173499A3BQ50422243-0689AE5E-0324-4634-B0D5-E4FF8D851576Q50987609-0E286F95-64E9-47F2-8BDA-211243E0D884Q52594204-491005D3-A085-46C8-B93F-F2CE2DBE8596Q79410745-DAB9FD11-D5B4-4EA5-9882-9D07F12CB1D0Q79445152-1E0B1273-57F5-454C-B5C7-BFC99A0A383FQ81544572-003387C0-71D6-4159-BC3C-0C50C4413CF9
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Tadayuki Tsujita
@ast
Tadayuki Tsujita
@en
Tadayuki Tsujita
@es
Tadayuki Tsujita
@sl
type
label
Tadayuki Tsujita
@ast
Tadayuki Tsujita
@en
Tadayuki Tsujita
@es
Tadayuki Tsujita
@sl
prefLabel
Tadayuki Tsujita
@ast
Tadayuki Tsujita
@en
Tadayuki Tsujita
@es
Tadayuki Tsujita
@sl
P106
P21
P31
P496
0000-0002-7189-0376
P569
2000-01-01T00:00:00Z